{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:45:40Z","timestamp":1772005540655,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T00:00:00Z","timestamp":1278806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s10549-010-1031-8","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T23:08:24Z","timestamp":1278889704000},"page":"529-535","source":"Crossref","is-referenced-by-count":24,"title":["RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis"],"prefix":"10.1007","volume":"125","author":[{"given":"Guo-Wu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Dong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,11]]},"reference":[{"key":"1031_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10689-008-9181-0","volume":"7","author":"DJ Hughes","year":"2008","unstructured":"Hughes DJ (2008) Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Fam Cancer 7:233\u2013244. doi: 10.1007\/s10689-008-9181-0","journal-title":"Fam Cancer"},{"key":"1031_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","volume":"23","author":"P Baumann","year":"1998","unstructured":"Baumann P, West SC (1998) Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci 23:247\u2013251. doi: 10.1016\/S0968-0004(98)01232-8","journal-title":"Trends Biochem Sci"},{"key":"1031_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2004.08.018","volume":"219","author":"J Thacker","year":"2005","unstructured":"Thacker J (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett 219:125\u2013135. doi: 10.1016\/j.canlet.2004.08.018","journal-title":"Cancer Lett"},{"key":"1031_CR4","first-page":"589","volume":"26","author":"L Hasselbach","year":"2005","unstructured":"Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW (2005) Characterisation of the promoter region of the human DBA-repair gene RAD51. Eur J Gynaecol Oncol 26:589\u2013598","journal-title":"Eur J Gynaecol Oncol"},{"key":"1031_CR5","first-page":"955","volume":"10","author":"WW Wang","year":"2001","unstructured":"Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP (2001) A single nucleotide polymorphism in the 5\u2019 untranslated region of RAD51 and risk of cancer among BRCA1\/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 10:955\u2013960","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1031_CR6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.bjc.6601837","volume":"90","author":"L Kadouri","year":"2004","unstructured":"Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T (2004) A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer 90:2002\u20132005. doi: 10.1038\/sj.bjc.6601837","journal-title":"Br J Cancer"},{"key":"1031_CR7","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1073\/pnas.051624098","volume":"98","author":"E Levy-Lahad","year":"2001","unstructured":"Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98:3232\u20133236. doi: 10.1073\/pnas.051624098","journal-title":"Proc Natl Acad Sci USA"},{"key":"1031_CR8","doi-asserted-by":"crossref","unstructured":"Antoniou AC, Sinilnikova OM, Simard J, L\u00e9on\u00e9 M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1\/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, G\u00f3rski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA) (2007) RAD51 135G\u00a0>\u00a0C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186\u20131200. doi: 10.1086\/522611","DOI":"10.1086\/522611"},{"key":"1031_CR9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejca.2008.10.021","volume":"45","author":"A Jakubowska","year":"2009","unstructured":"Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szyma\u0144ska-Pasternak J, Lener M, Narod SA, Lubi\u0144ski J, IHCC-Breast Cancer Study Group (2009) Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45:837\u2013842. doi: 10.1016\/j.ejca.2008.10.021","journal-title":"Eur J Cancer"},{"key":"1031_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-006-9364-z","volume":"103","author":"S Costa","year":"2007","unstructured":"Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F (2007) DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103:209\u2013217. doi: 10.1007\/s10549-006-9364-z","journal-title":"Breast Cancer Res Treat"},{"key":"1031_CR11","first-page":"457","volume":"12","author":"A Jakubowska","year":"2003","unstructured":"Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masoj\u0107 B, Nej K, Huzarska J, Byrski T, G\u00f3rski B, Lubi\u0144ski J (2003) Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 12:457\u2013459","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1031_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1055-9965.EPI-06-0562","volume":"16","author":"A Jakubowska","year":"2007","unstructured":"Jakubowska A, Gronwald J, Menkiszak J, G\u00f3rski B, Huzarski T, Byrski T, Edler L, Lubi\u00f1ski J, Scott RJ, Hamann U (2007) The RAD51 135G\u00a0>\u00a0C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16:270\u2013275. doi: 10.1158\/1055-9965.EPI-06-0562","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1031_CR13","first-page":"771","volume":"4","author":"RM Dufloth","year":"2005","unstructured":"Dufloth RM, Costa S, Schmitt F, Zeferino LC (2005) DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res 4:771\u2013782","journal-title":"Genet Mol Res"},{"key":"1031_CR14","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"1031_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1031_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"1031_CR17","first-page":"15","volume":"8","author":"A Tobias","year":"1999","unstructured":"Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tecnol Bull 8:15\u201317","journal-title":"Stata Tecnol Bull"},{"key":"1031_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1031_CR19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ejca.2005.09.035","volume":"42","author":"I Gal","year":"2006","unstructured":"Gal I, Kimmel G, Gershoni-Baruch R, Papa MZ, Dagan E, Shamir R, Friedman E (2006) A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women. Eur J Cancer 42:1129\u20131134. doi: 10.1016\/j.ejca.2005.09.035","journal-title":"Eur J Cancer"},{"key":"1031_CR20","first-page":"161","volume":"56","author":"H Romanowicz-Makowska","year":"2005","unstructured":"Romanowicz-Makowska H, Smolarz B, Kulig A (2005) Germline BRCA1 mutations and G\/C polymorphism in the 5\u2019-untranslated region of the RAD51 gene in Polish women with breast cancer. Pol J Pathol 56:161\u2013165","journal-title":"Pol J Pathol"},{"key":"1031_CR21","first-page":"548","volume":"21","author":"H Romanowicz-Makowska","year":"2006","unstructured":"Romanowicz-Makowska H, Smolarz B (2006) Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer. Pol Merkur Lekarski 21:548\u2013550 Polish","journal-title":"Pol Merkur Lekarski"},{"key":"1031_CR22","first-page":"55","volume":"21","author":"H Romanowicz-Makowska","year":"2006","unstructured":"Romanowicz-Makowska H, Smolarz B, Kulig A (2006) The G\/C polymorphism of RAD51 gene in breast cancer. Pol Merkur Lekarski 21:55\u201358 Polish","journal-title":"Pol Merkur Lekarski"},{"key":"1031_CR23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.18388\/abp.2003_3733","volume":"50","author":"J Blasiak","year":"2003","unstructured":"Blasiak J, Przyby\u0142owska K, Czechowska A, Zadrozny M, Perty\u0144ski T, Ryka\u0142a J, Ko\u0142aci\u0144ska A, Morawiec Z, Drzewoski J (2003) Analysis of the G\/C polymorphism in the 5\u2019-untranslated region of the RAD51 gene in breast cancer. Acta Biochim Pol 50:249\u2013253","journal-title":"Acta Biochim Pol"},{"key":"1031_CR24","first-page":"156","volume":"28","author":"H Romanowicz-Makowska","year":"2006","unstructured":"Romanowicz-Makowska H, Smolarz B, Zadrozny M, Kulig A (2006) Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer. Exp Oncol 28:156\u2013159","journal-title":"Exp Oncol"},{"key":"1031_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mrfmmm.2008.09.014","volume":"648","author":"E Synowiec","year":"2008","unstructured":"Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648:65\u201372. doi: 10.1016\/j.mrfmmm.2008.09.014","journal-title":"Mutat Res"},{"key":"1031_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yexmp.2009.04.005","volume":"87","author":"R Krupa","year":"2009","unstructured":"Krupa R, Synowiec E, Pawlowska E, Morawiec Z, Sobczuk A, Zadrozny M, Wozniak K, Blasiak J (2009) Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol 87:32\u201335. doi: 10.1016\/jyexmp2009.04.005","journal-title":"Exp Mol Pathol"},{"key":"1031_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cancergencyto.2007.05.024","volume":"178","author":"L Jara","year":"2007","unstructured":"Jara L, Acevedo ML, Blanco R, Castro VG, Bravo T, G\u00f3mez F, Waugh E, Peralta O, Cabrera E, Reyes JM, Ampuero S, Gonz\u00e1lez-Hormaz\u00e1bal P (2007) RAD51 135G\u00a0>\u00a0C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 178:65\u201369. doi: 10.1016\/j.cancergencyto.2007.05.024","journal-title":"Cancer Genet Cytogenet"},{"key":"1031_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-005-0672-5","volume":"94","author":"T Sliwinski","year":"2005","unstructured":"Sliwinski T, Krupa R, Majsterek I, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Zadrozny M, Blasiak J (2005) Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 94:105\u2013109. doi: 10.1007\/s10549-005-0672-5","journal-title":"Breast Cancer Res Treat"},{"key":"1031_CR29","doi-asserted-by":"crossref","unstructured":"Jara L, Dubois K, Gaete D, de Mayo T, Ratkevicius N, Bravo T, Margarit S, Blanco R, G\u00f3mez F, Waugh E, Peralta O, Reyes JM, Ib\u00e1\u00f1ez G, Gonz\u00e1lez-Hormaz\u00e1bal P (2010) Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res Treat. doi: 10.1007\/s10549-009-0709-2","DOI":"10.1007\/s10549-009-0709-2"},{"key":"1031_CR30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/hmg\/11.12.1399","volume":"11","author":"B Kuschel","year":"2002","unstructured":"Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399\u20131407. doi: 10.1093\/hmg\/11.12.1399","journal-title":"Hum Mol Genet"},{"key":"1031_CR31","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1158\/1078-0432.CCR-04-2534","volume":"11","author":"KM Lee","year":"2005","unstructured":"Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH, Park CG, Wei Q, Kang D (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11:4620\u20134626. doi: 10.1158\/1078-0432.CCR-04-2534","journal-title":"Clin Cancer Res"},{"key":"1031_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1055-9965.EPI-04-0335","volume":"14","author":"PM Webb","year":"2005","unstructured":"Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:319\u2013323. doi: 10.1158\/1055-9965.EPI-04-0335","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1031_CR33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.breast.2006.03.008","volume":"15","author":"TW Chang","year":"2006","unstructured":"Chang TW, Wang SM, Guo YL, Tsai PC, Huang CJ, Huang W (2006) Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast 15:754\u2013761. doi: 10.1016\/j.breast.2006.03.008","journal-title":"Breast"},{"key":"1031_CR34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1158\/1055-9965.EPI-08-0065","volume":"17","author":"J Brooks","year":"2008","unstructured":"Brooks J, Shore RE, Zeleniuch-Jacquotte A, Currie D, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I (2008) Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:1016\u20131019. doi: 10.1158\/1055-9965.EPI-08-0065","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1031_CR35","first-page":"973","volume":"39","author":"R Hu","year":"2008","unstructured":"Hu R, Wei Y, Jiang WJ, Yao WX, Long QM, Zhang JH, Liang Y, Tang XL (2008) Association of polymorphisms of N372H in BRCA2 gene and 135G\/C in RAD51 gene and breast cancers. Sichuan Da Xue Xue Bao Yi Xue Ban 39:973\u2013975 Chinese","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"1031_CR36","doi-asserted-by":"crossref","unstructured":"Akisik E, Yazici H, Dalay N (2010) ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer. Mol Biol Rep. doi: 10.1007\/s11033-010-0113-3","DOI":"10.1007\/s11033-010-0113-3"},{"key":"1031_CR37","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"R Wooster","year":"2003","unstructured":"Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339\u20132347. doi: 10.1056\/NEJMra012284","journal-title":"N Engl J Med"},{"key":"1031_CR38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/sim.1023","volume":"21","author":"JA Berlin","year":"2002","unstructured":"Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-Lymphocyte Antibody Induction Therapy Study Group (2002) Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 21:371\u2013387","journal-title":"Stat Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1031-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1031-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1031-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T20:53:49Z","timestamp":1591476829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1031-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1031-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,11]]}}}